Novo Nordisk has been investigating CagriSema through the REDEFINE programme, a series of Phase 3 clinical trials in adults with overweight or obesity
Gastrointestinal symptoms Nausea, diarrhoea, vomiting, constipation, abdominal pain, indigestion/dyspepsia, abdominal distension, belching/eructation, gastroenteritis, and gastroesophageal reflux disease Headache Fatigue Dizziness Hypoglycaemia Diabetic retinopathy How to prevent side effects of semaglutide
Eat Enough Protein Protein helps stabilize blood sugar and preserve muscle
Detailed medical and family history, a current medication review, baseline renal function through creatinine and eGFR, liver function tests, fasting glucose, and TSH
The medication is also effective for menopause-related weight gain